SEC Form 4 · accession 0001567619-19-001305
Medpace Holdings, Inc. · MEDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
August J. Troendle
Officer — President & CEO · Director · 10% Owner
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001668397
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 15, 2019 | S | 600 | $61.00 | D | 8,150,525 | I | By Medpace Investors, LLC |
| Common StockF1,F4,F3 | Jan 16, 2019 | S | 7,222 | $61.57 | D | 8,143,303 | I | By Medpace Investors, LLC |
| Common StockF1,F5,F3 | Jan 17, 2019 | S | 8,760 | $61.17 | D | 8,134,543 | I | By Medpace Investors, LLC |
| Common Stock | holding | — | — | — | 603,702 | D | ||
| Common Stock | holding | — | — | — | 10,000 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018.
- F2The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F3The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F4The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $62.07. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F5The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.